Sitagliptin / Metformin hydrochloride Sun 欧盟 - 丹麦文 - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Lutetium (177Lu) chloride Billev (previously Illuzyce) 欧盟 - 丹麦文 - EMA (European Medicines Agency)

lutetium (177lu) chloride billev (previously illuzyce)

billev pharma aps - lutetium (177lu) chloride - radionuklidbilleddannelse - terapeutiske radioaktive lægemidler - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.

Cegfila (previously Pegfilgrastim Mundipharma) 欧盟 - 丹麦文 - EMA (European Medicines Agency)

cegfila (previously pegfilgrastim mundipharma)

mundipharma corporation (ireland) limited - pegfilgrastim - neutropeni - immunostimulants, - reduktion i varigheden af neutropeni og forekomst af febril neutropeni hos voksne patienter behandlet med cytotoksisk kemoterapi for malignitet (med undtagelse af kronisk myeloid leukæmi og myelodysplastisk syndromer).

Sitagliptin / Metformin hydrochloride Mylan 欧盟 - 丹麦文 - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Naltrexone "POA Pharma" 50 mg filmovertrukne tabletter 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

naltrexone "poa pharma" 50 mg filmovertrukne tabletter

poa pharma scandinavia ab - naltrexonhydrochlorid - filmovertrukne tabletter - 50 mg

Donepezil "Aurobindo" 10 mg filmovertrukne tabletter 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

donepezil "aurobindo" 10 mg filmovertrukne tabletter

aurobindo pharma (malta) limited - donepezilhydrochlorid - filmovertrukne tabletter - 10 mg

Donepezil "Aurobindo" 5 mg filmovertrukne tabletter 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

donepezil "aurobindo" 5 mg filmovertrukne tabletter

aurobindo pharma (malta) limited - donepezilhydrochlorid - filmovertrukne tabletter - 5 mg

Ondansetron "Aurobindo" 4 mg filmovertrukne tabletter 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

ondansetron "aurobindo" 4 mg filmovertrukne tabletter

aurobindo pharma (malta) limited - ondansetronhydrochloriddihydrat - filmovertrukne tabletter - 4 mg